CompuGroup Medical Societas Europaea (COP) PT Set at €62.00 by Commerzbank Ag

CompuGroup Medical Societas Europaea (ETR:COP) has been given a €62.00 ($72.09) target price by equities research analysts at Commerzbank Ag in a research note issued on Monday. The brokerage presently has a “buy” rating on the stock. Commerzbank Ag’s price objective points to a potential upside of 12.73% from the company’s current price.

A number of other equities research analysts also recently commented on COP. Baader Bank set a €52.00 ($60.47) price objective on CompuGroup Medical Societas Europaea and gave the company a “buy” rating in a report on Friday, July 21st. Deutsche Bank AG set a €60.00 ($69.77) price objective on CompuGroup Medical Societas Europaea and gave the company a “buy” rating in a report on Tuesday, August 1st. Warburg Research set a €52.00 ($60.47) price objective on CompuGroup Medical Societas Europaea and gave the company a “neutral” rating in a report on Thursday, August 3rd. Finally, Berenberg Bank set a €53.00 ($61.63) price objective on CompuGroup Medical Societas Europaea and gave the company a “neutral” rating in a report on Friday, August 4th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of €58.17 ($67.64).

Shares of CompuGroup Medical Societas Europaea (ETR COP) opened at €55.00 ($63.95) on Monday. CompuGroup Medical Societas Europaea has a fifty-two week low of €36.06 ($41.93) and a fifty-two week high of €52.94 ($61.56).

ILLEGAL ACTIVITY NOTICE: “CompuGroup Medical Societas Europaea (COP) PT Set at €62.00 by Commerzbank Ag” was reported by Week Herald and is the sole property of of Week Herald. If you are reading this report on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this report can be read at https://weekherald.com/2017/11/15/compugroup-medical-societas-europaea-cop-pt-set-at-62-00-by-commerzbank-ag.html.

CompuGroup Medical Societas Europaea Company Profile

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician’s networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for CompuGroup Medical Societas Europaea (ETR:COP)

Receive News & Ratings for CompuGroup Medical Societas Europaea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuGroup Medical Societas Europaea and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply